A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia

por Chiarini, Francesca, Lonetti, Annalisa, Teti, Gabriella, Orsini, Ester, Bressanin, Daniela, Cappellini, Alessandra, Ricci, Francesca, Tazzari, Pier Luigi, Ognibene, Andrea, Falconi, Mirella, Pagliaro, Pasqualepaolo, Iacobucci, Ilaria, Martinelli, Giovanni, Amadori, Sergio, McCubrey, James A., Martelli, Alberto M.
Publicado 2012